These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20201005)

  • 1. Carisbamate in essential tremor: brief report of a proof of concept study.
    Elble RJ; Biondi DM; Ascher S; Wiegand F; Hulihan J
    Mov Disord; 2010 Apr; 25(5):634-8. PubMed ID: 20201005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS; Edwards K; Tarsy D
    Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
    Ferrara JM; Kenney C; Davidson AL; Shinawi L; Kissel AM; Jankovic J
    J Neurol Sci; 2009 Oct; 285(1-2):195-7. PubMed ID: 19631949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.
    Trenité DG; French JA; Hirsch E; Macher JP; Meyer BU; Grosse PA; Abou-Khalil BW; Rosenfeld WE; van Gerven J; Novak GP; Parmeggiani L; Schmidt B; Gibson D; Guerrini R
    Epilepsy Res; 2007 May; 74(2-3):193-200. PubMed ID: 17448639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
    Pahwa R; Lyons KE
    Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.
    Faught E; Holmes GL; Rosenfeld WE; Novak G; Neto W; Greenspan A; Schmitt J; Yuen E; Reines S; Haas M
    Neurology; 2008 Nov; 71(20):1586-93. PubMed ID: 19001248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
    Smith T; DiBernardo A; Shi Y; Todd MJ; Brashear HR; Ford LM
    Pain Pract; 2014 Apr; 14(4):332-42. PubMed ID: 23692321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A; Martin FC; Kang GA; Vanek Z
    Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Salemi JL; Siraj S; Wilson MC; Sullivan KL
    Mov Disord; 2007 Aug; 22(11):1660-3. PubMed ID: 17580330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in essential tremor: a double-blind, placebo-controlled trial.
    Ondo WG; Jankovic J; Connor GS; Pahwa R; Elble R; Stacy MA; Koller WC; Schwarzman L; Wu SC; Hulihan JF;
    Neurology; 2006 Mar; 66(5):672-7. PubMed ID: 16436648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
    Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
    Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).
    Melmed C; Moros D; Rutman H
    Mov Disord; 2007 Apr; 22(5):723-7. PubMed ID: 17265458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly.
    Levy R; Ragueneau-Majlessi I; Solanki B; Zannikos P; Yao C; Novak G
    Epilepsy Res; 2008 Mar; 79(1):22-30. PubMed ID: 18280116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.
    Lorenz D; Hagen K; Ufer M; Cascorbi I; Deuschl G; Volkmann J
    Neurology; 2006 Jun; 66(11):1753-5. PubMed ID: 16769957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma knife thalamotomy for disabling tremor: a blinded evaluation.
    Lim SY; Hodaie M; Fallis M; Poon YY; Mazzella F; Moro E
    Arch Neurol; 2010 May; 67(5):584-8. PubMed ID: 20457958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.